Inari, the SEEDesign™ company, has named Dr. Vivien Bonazzi chief data officer, effective April 1. A leading biomedical data scientist, Bonazzi is tasked with further elevating the company’s AI-powered predictive design capabilities for ongoing development of step-change seed products.
Data management and deployment are fundamental to Inari, where scientists are leveraging the latest breakthroughs in artificial intelligence to rapidly build exponential new plant genomic knowledge and applications that guide its unmatched multiplex gene editing toolbox. Bonazzi will oversee the methodologies, technologies, and digital infrastructure to further accelerate the company’s ability to bring truly novel products to market.
“Data underpins everything we do at Inari, so we are thrilled to have Vivien’s leadership in this area,” said Inari CEO Ponsi Trivisvavet. “Her experience helps fortify our cutting-edge SEEDesign™ technology platform, and her biomedical background brings fresh perspectives to help us unlock the full potential of seed.”
“I have dedicated my career to utilizing data to benefit people. Helping to drive Inari’s innovative technology to support global food system sustainability is a meaningful opportunity to continue this mission,” said Dr. Vivien Bonazzi. ” I am eager to leverage my expertise to enhance Inari’s capabilities and contribute to this essential work.”
Prior to joining Inari, Dr. Vivien Bonazzi served as chief biomedical data scientist and managing director at Deloitte Consulting LLP. She previously was a senior advisor in the Office of the Director at National Institutes of Health (NIH) and co-founded the NIH Data Commons, pioneering new methods for sharing and analyzing biomedical data. She has also held several roles in both the private and nonprofit sectors, including Celera Genomics, Invitrogen and The Institute for Genomic Research.
